Health

Weight-Loss Drug Price Wars Are Upending Big Pharma’s Business Model

Prices for popular GLP-1 weight-loss drugs are falling rapidly, pressuring pharmaceutical companies to overhaul pricing strategies and rethink long-term business…

2 weeks ago

Republicans are concerned about the political repercussions of reducing Medicaid

Republicans are backing away from broad proposals to slash federal funding to Medicaid and inching toward a more modest approach,…

9 months ago

Trump has selected a MAHA influencer to be the new surgeon general, after changing his initial choice

The White House pulled the nomination of Janette Nesheiwat to be the surgeon general in favor of Casey Means, a…

10 months ago

Californians are very doubtful of Trump’s intention to reopen Alcatraz

ALCATRAZ ISLAND, Calif. — The barred cell doors are so rusted they can’t close. Century-old lead paint is peeling off…

10 months ago

StepStone’s latest growth-equity fund has exceeded $700 million

StepStone Group (NASDAQ: STEP) said its latest middle-market growth-equity fund, StepStone Growth Partners V, closed at $720 million, beating its $700 million target.…

10 months ago

Novo Nordisk has secured a significant legal victory, effectively prohibiting the sale of many compounded versions of its popular drugs Wegovy and Ozempic

Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the…

10 months ago

One of the country’s leading Alzheimer’s projects is in jeopardy

Andrea Gilbert thought she knew what would happen to her brain. The 79-year-old retired attorney, who has Alzheimer’s disease and…

10 months ago

As His Chronic Disease Tour Wraps, Kennedy Hits His Stride

The sun was bursting through the sandstone arch of Window Rock in northeastern Arizona, and Health Secretary Robert F. Kennedy…

10 months ago

This website uses cookies.